TY - JOUR
T1 - Cardiac allograft vasculopathy can be distinguished from donor-transmitted coronary atherosclerosis by optical coherence tomography imaging in a heart transplantation recipient double layered intimal thickness
AU - Imamura, Teruhiko
AU - Kinugawa, Koichiro
AU - Murasawa, Takahide
AU - Kagami, Yukie
AU - Endo, Miyoko
AU - Muraoka, Hironori
AU - Fujino, Takeo
AU - Inaba, Toshiro
AU - Maki, Hisataka
AU - Hatano, Masaru
AU - Kinoshita, Osamu
AU - Nawata, Kan
AU - Kyo, Shunei
AU - Komuro, Issei
AU - Ono, Minoru
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 2014
Y1 - 2014
N2 - Although survival after heart transplantation (HTx) has improved in recent years, cardiac allograft vasculopathy (CAV) is still the leading cause of remote morbidity and mortality in HTx recipients, partly because of diffi culty with its diagnosis. In general, routine surveillance for CAV is advocated with coronary angiography accompanied by intravascular ultrasound (IVUS) if necessary. However, these modalities have limitations with respect to low spatial resolution, and suffi cient qualitative/quantitative assessment of coronary intima has not been accomplished. Recently, optical coherence tomography (OCT) has emerged as a novel intracoronary imaging technique using an optical analogue of ultrasound with a spatial resolution of 10-20 μm, which is 10 times greater than IVUS. We here experienced a 49-year-old male who received a HTx 3 years ago, and OCT was executed during low molecular weight dextran injection. OCT demonstrated distinct double intimal layers probably consisting of a donor-transmitted atherosclerotic layer and an inner intimal proliferation due to CAV, which was indistinguishable by IVUS and virtual histological analyses. We believe that OCT imaging is not only a new loadstar during treatment of CAV but also a new generation modality for screening for early CAV in HTx recipients.
AB - Although survival after heart transplantation (HTx) has improved in recent years, cardiac allograft vasculopathy (CAV) is still the leading cause of remote morbidity and mortality in HTx recipients, partly because of diffi culty with its diagnosis. In general, routine surveillance for CAV is advocated with coronary angiography accompanied by intravascular ultrasound (IVUS) if necessary. However, these modalities have limitations with respect to low spatial resolution, and suffi cient qualitative/quantitative assessment of coronary intima has not been accomplished. Recently, optical coherence tomography (OCT) has emerged as a novel intracoronary imaging technique using an optical analogue of ultrasound with a spatial resolution of 10-20 μm, which is 10 times greater than IVUS. We here experienced a 49-year-old male who received a HTx 3 years ago, and OCT was executed during low molecular weight dextran injection. OCT demonstrated distinct double intimal layers probably consisting of a donor-transmitted atherosclerotic layer and an inner intimal proliferation due to CAV, which was indistinguishable by IVUS and virtual histological analyses. We believe that OCT imaging is not only a new loadstar during treatment of CAV but also a new generation modality for screening for early CAV in HTx recipients.
UR - http://www.scopus.com/inward/record.url?scp=84897059233&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84897059233&partnerID=8YFLogxK
U2 - 10.1536/ihj.13-279
DO - 10.1536/ihj.13-279
M3 - Article
C2 - 24632967
AN - SCOPUS:84897059233
SN - 1349-2365
VL - 55
SP - 178
EP - 180
JO - International heart journal
JF - International heart journal
IS - 2
ER -